A detailed history of Christopher J. Hasenberg, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Christopher J. Hasenberg, Inc holds 302 shares of PFE stock, worth $7,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares
302
Previous 142 112.68%
Holding current value
$7,746
Previous $3,000 166.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$27.7 - $31.39 $4,432 - $5,022
160 Added 112.68%
302 $8,000
Q1 2024

Apr 24, 2024

BUY
$25.89 - $29.73 $3,676 - $4,221
142 New
142 $3,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Christopher J. Hasenberg, Inc Portfolio

Follow Christopher J. Hasenberg, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Christopher J. Hasenberg, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Christopher J. Hasenberg, Inc with notifications on news.